Valeria Miller

Biochemistry, Genetics and Molecular Biology · Life Sciences

8h-index364citations28works0.02yr avg
OpenAlex↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cancer, Hypoxia, and Metabolism(10), Cancer Immunotherapy and Biomarkers(8), Cancer Cells and Metastasis(5), Angiogenesis and VEGF in Cancer(4), Immune cells in cancer(4)

Publications28 total

Data from Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2023Open Access
Supplementary methods and supplementary figures 1 through 4 from Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2023Open Access
Data from Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2023Open Access
Supplementary methods and supplementary figures 1 through 4 from Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2023Open Access
Supplementary Materials and Methods, Supplementary Tables 1 and 2, and Supplementary Figures 1 through 8 from Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2023Open Access
Supplementary Materials and Methods, Supplementary Tables 1 and 2, and Supplementary Figures 1 through 8 from Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2023Open Access
Data from Blocking IL1β Pathway Following Paclitaxel Chemotherapy Slightly Inhibits Primary Tumor Growth but Promotes Spontaneous Metastasis
2023Open Access
Data from Differential Therapeutic Effects of Anti–VEGF-A Antibody in Different Tumor Models: Implications for Choosing Appropriate Tumor Models for Drug Testing
2023Open Access
Supplemental Materials and Methods from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Supplemental Figure Legends from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Supplemental Figures S1-S6 from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Data from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Supplemental Tables S1-S3 from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Data from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Supplemental Figures S1-S6 from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Supplemental Figure Legends from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Supplemental Materials and Methods from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Supplemental Tables S1-S3 from Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
2023Open Access
Macrophage-Induced Lymphangiogenesis and Metastasis following Paclitaxel Chemotherapy Is Regulated by VEGFR3
Cell Reports·2016· 112 citedOpen Access
Evidence Implicating Immunological Host Effects in the Efficacy of Metronomic Low-Dose Chemotherapy
Cancer Research·2016· 58 cited
page 1 of 2Next →

Frequent Co-authors

Yuval Shaked(28), Dror Alishekevitz(16), Ofrat Beyar‐Katz(13), Tali Voloshin(12), Ella Fremder(12), Ksenia Magidey(12), Elizabeth Pham(11), Santosh Hariharan(11), Shan Man(11), Florence T.H. Wu(11), Robert S. Kerbel(11), Ping Xu(10), Rotem Bril(8), David Loven(7), David Andrews(7), Moran Benhar(6), Limor Kaneti(5), Elina Isakov(5), Irena Kaplanov(5), Elena Voronov(5)